0001555280-21-000100.txt : 20210216
0001555280-21-000100.hdr.sgml : 20210216
20210216171616
ACCESSION NUMBER: 0001555280-21-000100
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210211
FILED AS OF DATE: 20210216
DATE AS OF CHANGE: 20210216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly Robert Edward
CENTRAL INDEX KEY: 0001798683
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35797
FILM NUMBER: 21640844
MAIL ADDRESS:
STREET 1: C/O ZOETIS INC.
STREET 2: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zoetis Inc.
CENTRAL INDEX KEY: 0001555280
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460696167
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 973-822-7000
MAIL ADDRESS:
STREET 1: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
4
1
wf-form4_161351374187911.xml
FORM 4
X0306
4
2021-02-11
0
0001555280
Zoetis Inc.
ZTS
0001798683
Kelly Robert Edward
C/O ZOETIS INC.
10 SYLVAN WAY
PARSIPPANY
NJ
07054
0
1
0
0
Executive Vice President
Common Stock
2021-02-11
4
M
0
821
26
A
10029
D
Common Stock
2021-02-11
4
M
0
729
30.89
A
10758
D
Common Stock
2021-02-11
4
S
0
2054
161.15
D
8704
D
Stock Option
2021-02-11
4
M
0
821
0
D
Common Stock
821.0
51513
D
Stock Option
2021-02-11
4
M
0
729
0
D
Common Stock
729.0
50784
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2020.
The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.
821 options granted January 31, 2013 at an exercise price of $26.00 per option.
Each option vests on the third anniversary of the date of grant.
Each option expires on the tenth anniversary of the date of grant.
9,022 options granted January 31, 2013 at an exercise price of $26.00 per option; 8,739 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option.
729 options granted March 4, 2014 at an exercise price of $30.89 per option.
9,022 options granted January 31, 2013 at an exercise price of $26.00 per option; 8,010 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option.
/s/ Katherine H. Walden, as Attorney-in-Fact
2021-02-16